Delivery Order SPE2DB24D1205-SPE2DB25FCYLR
- Not listed
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,688.23 firm fixed-price delivery order is for the pharmaceutical product ENTYVIO 108 MG/0.68 ML PEN 0.68ML. The contract has an ultimate completion date of April 8, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,376.46 firm fixed-price delivery order is for the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication. The contract has an ultimate completion date of January 9, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,458.82 firm fixed-price delivery order is for the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication. The contract has an ultimate completion date of February 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,917.64 firm fixed-price contract is for the delivery of the pharmaceutical product ENTYVIO 108 MG/0.68 ML PEN 0.68ML. The contract has an ultimate completion date of June 10, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,458.82, is for the delivery of the pharmaceutical product ENTYVIO 108 MG/0.68 ML PEN 0.68ML. It is a firm fixed-price delivery order contract with an ultimate completion date of April 17, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides $1,229.41 for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication. The contract is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of February 4, 2025. The contract is a firm-fixed-price arrangement and does not utilize any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,688.23, is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication. This is a firm fixed-price delivery order contract with an ultimate completion date of April 11, 2025. The contract is not set aside for any specific socioeconomic program. AmerisourceBergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,229.41, is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 23, 2024. The contract was not set aside for any specific business category....
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $7,376.46. The contract is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a pharmaceutical product, with a period of performance through June 9, 2025. This appears to be a non-set-aside contract, meaning it was open to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,917.64, is a delivery order for the product ENTYVIO 108 MG/0.68 ML PEN 0.68ML. It is a firm fixed-price contract with a completion date of June 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCYLRDelivery Order
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $2,458.82 firm fixed-price delivery order is for the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a pharmaceutical product. The contract has an ultimate completion date of August 1, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. The contract award is not designated as a set-aside.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 7/11/25 |